Medyczne Centrum Hetmańska
About Medyczne Centrum Hetmańska
"Specjaliści reumatolodzy, pełna diagnostyka i leczenie. Konsultacje rematologiczne, densytometria, usg stawów, kapilaroskopia"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abivax S.A.
2
Bristol-Myers Squibb
2
Janssen Research & Development, LLC
2
Pfizer
2
Arana Therapeutics Ltd
1
Celon Pharma SA
1
Corbus Pharmaceuticals Inc.
1
Eupraxia Pharmaceuticals Inc.
1
Hoffmann-La Roche
1
ImmuPharma
1
Levicept
1
Clinical Trials at Medyczne Centrum Hetmańska
During the past decade, Medyczne Centrum Hetmańska conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on
average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
2009-04-01
2009-12-01
Terminated
13
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis
2009-10-31
2014-01-28
Completed
1,162
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
2011-12-01
2014-03-01
Completed
183
A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
2015-03-01
2018-01-01
Completed
202
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
2017-07-12
2020-11-10
Completed
741
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)
2017-08-24
2019-11-18
Completed
383
An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus
2017-09-21
2021-10-28
Completed
363
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medyczne Centrum Hetmańska" #1 sponsor was "Abivax S.A." with 2 trials, followed by "Bristol-Myers Squibb" with 2 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Arana Therapeutics Ltd"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medyczne Centrum Hetmańska"
#1 collaborator was "NBCD A/S" with 1 trials as a collaborator, "National Center for Research and Development, Poland" with 1 trials as a collaborator and "Nordic Bioscience Clinical Development (NBCD)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Medyczne Centrum Hetmańska
According to Clinical.Site data, the most researched conditions in "Medyczne Centrum Hetmańska" are
"Rheumatoid Arthritis" (5 trials), "Arthritis, Psoriatic" (2 trials), "Diffuse Cutaneous Systemic Sclerosis" (2 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "Medyczne Centrum Hetmańska" in a lesser frequency.
Clinical Trials Intervention Types at Medyczne Centrum Hetmańska
Most popular intervention types in "Medyczne Centrum Hetmańska" are "Drug" (15 trials), "Other" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "BMS-986165" (2 trials), "Guselkumab" (2 trials), "Methotrexate" (2 trials) and "ABX464" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medyczne Centrum Hetmańska
The vast majority of trials in "Medyczne Centrum Hetmańska" are
16 trials for "All" genders.
Clinical Trials Status at Medyczne Centrum Hetmańska
Currently, there are NaN active trials in "Medyczne Centrum Hetmańska".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Medyczne Centrum Hetmańska,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Medyczne Centrum Hetmańska, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".